利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

18 条记录 (耗时 0.038 秒)

    Method and apparatus for efficiently testing RAMBUS memory devices
    8.
    发明授权
    Method and apparatus for efficiently testing RAMBUS memory devices 失效
    用于有效测试RAMBUS存储器件的方法和装置

    公开(公告)号：US06314036B1

    公开(公告)日：2001-11-06

    申请号：US09708692

    申请日：2000-11-07

    申请人： Christopher B. Cooper ,  Brian L. Brown ,  Thanh K. Mai

    发明人： Christopher B. Cooper ,  Brian L. Brown ,  Thanh K. Mai

    IPC分类号： C13

    CPC分类号： G11C7/1072

    摘要： A RAMBUS dynamic random access memory includes a test control circuit that selectively couples a row address latch to either a row sense control signal or a CMD control signal. In a normal operating mode, the test control circuit couples the row address latch to the row sense control signal so that the row sense control signal both latches a row address and senses a row of memory cells corresponding to the latched address. Prior to conducting a core noise test, the test control circuit couples the row address latch to the CMD control signal so that the row address is latched by the CMD control signal, and the row sense control signal only functions during the core noise test to sense a row corresponding to the latched row. The memory also includes a multiplexer that receives a time-multiplexed data/address bus and simultaneously couples a first part of the data/address bus to an internal data bus and a second part of the data/address bus to an internal address bus.

    摘要翻译： RAMBUS动态随机存取存储器包括选择性地将行地址锁存器耦合到行检测控制信号或CMD控制信号的测试控制电路。 在正常操作模式下，测试控制电路将行地址锁存器耦合到行读控制信号，使得行读控制信号都锁存行地址并且感测与锁存地址对应的一行存储单元。 在进行核心噪声测试之前，测试控制电路将行地址锁存器耦合到CMD控制信号，使得行地址由CMD控制信号锁存，并且行检测控制信号仅在核心噪声测试期间起作用以感测 一行对应于锁存行。 存储器还包括多路复用器，其接收时间复用的数据/地址总线，并同时将数据/地址总线的第一部分耦合到内部数据总线以及数据/地址总线的第二部分到内部地址总线。

    Supersonic all gas-phase iodine laser
    9.
    发明授权
    Supersonic all gas-phase iodine laser 失效
    超音速全相气相碘激光

    公开(公告)号：US07453917B1

    公开(公告)日：2008-11-18

    申请号：US11179187

    申请日：2005-07-12

    申请人： Christopher B. Cooper ,  Gerald C. Manke ,  Gordon D. Hager ,  Timothy J. Madden

    发明人： Christopher B. Cooper ,  Gerald C. Manke ,  Gordon D. Hager ,  Timothy J. Madden

    IPC分类号： H01S3/22

    CPC分类号： H01S3/2215 ,  H01S3/0953

    摘要： A continuous wave laser based on the electronic I*(2P½)−I(2P 3/2) transition of atomic iodine at 1.315 microns from the NCl(a1Δ)+I(2P 3/2) energy transfer reaction using a transverse flow device having gas flow from an upstream subsonic combustor section through a converging-diverging supersonic slit nozzle to a downstream supersonic section and an intersecting optical resonator. Laser operation is achieved through the transformation of the gas phase chemical reagents, D2 (deuterium), F2 (fluorine), NF3 (nitrogen trifluoride), DCl (deuterium chloride) HI (hydrogen iodide) in the subsonic section and HN3 (hydrogen azide) in the supersonic section.

    摘要翻译： 基于电子I *（ 2 P 1/2）的连续波激光器 >）从NCl（α-1 +）+ I（2+ 3/3/2）能量转移反应在1.315微米的原子碘转变 使用具有来自上游亚音速燃烧器部分的气流通过会聚发散超音速狭缝喷嘴到下游超音速部分的横向流动装置和相交的光学谐振器。 激光操作是通过气相化学试剂D 2（氘），F 2（氟），NF 3 N（Ⅳ） 三氟化氮），亚音速部分中的DC1（氘氯化物）HI（碘化氢）和超音速部分中的HN 3（叠氮化氢）。

    Thiazole derivatives
    10.
    发明授权
    Thiazole derivatives 失效
    噻唑衍生物

    公开(公告)号：US06720427B2

    公开(公告)日：2004-04-13

    申请号：US10144403

    申请日：2002-05-13

    申请人： Mark A. Sanner ,  Chris J. Helal ,  Christopher B. Cooper

    发明人： Mark A. Sanner ,  Chris J. Helal ,  Christopher B. Cooper

    IPC分类号： C07D21722

    CPC分类号： C07D277/62 ,  C07D277/42 ,  C07D277/46 ,  C07D277/48 ,  C07D277/64 ,  C07D417/12 ,  C07D417/14

    摘要： The invention provides compounds of formula 1 wherein R1, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula 1 are indicated to have activity inhibiting cdk5, cdk2, and GSK-3. Pharmaceutical compositions and methods comprising compounds of formula 1 for treating diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission are described. Also described are pharmaceutical compositions and methods comprising compounds of formula 1 for treating male fertility and sperm motility; diabetes mellitus; impaired glucose tolerance; metabolic syndrome or syndrome X; polycystic ovary syndrome; adipogenesis and obesity; myogenesis and frailty, for example age-related decline in physical performance; acute sarcopenia, for example muscle atrophy and/or cachexia associated with burns, bed rest, limb immobilization, or major thoracic, abdominal, and/or orthopedic surgery; sepsis; hair loss, hair thinning, and balding; and immunodeficiency.

    摘要翻译： 本发明提供了式1化合物，其中R 1，R 3和R 4如上定义，及其药学上可接受的盐。 式1的化合物表示具有抑制cdk5，cdk2和GSK-3的活性。 描述了包含式1化合物的药物组合物和方法，用于治疗包括异常细胞生长如癌症和神经变性疾病和病症以及受多巴胺神经传递影响的疾病和病症。 还描述了包含用于治疗雄性生育力和精子活力的式1化合物的药物组合物和方法; 糖尿病 葡萄糖耐量降低; 代谢综合征或综合征X; 多囊卵巢综合征; 脂肪生成和肥胖; 造血和虚弱，例如年龄相关的身体表现下降; 急性肌肉减少症，例如与烧伤，卧床休息，肢体固定或主要胸部，腹部和/或整形外科手术相关的肌肉萎缩和/或恶病质; 败血症 脱发，脱发，秃头; 和免疫缺陷。